Allergan slammed as federal judge invalidates Restasis patents, slaps Mohawk deal
For weeks now Allergan has been hammered by a growing legion of critics in and out of Congress for its recent decision to shift control …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
